KRAS and neoplasm: We clarified the hereditary and evolutional connection between neoplasm and stroma, explored a novel prognostic marker based on stromal genomic status, and validated that KRAS-mutant stroma cells might derive from tumor cells with multi-lineage differentiation potential and promote tumorigenesis via EMT.